Search type | Study: first author; publication date | Brief study design | Sample size (N); characteristics | Prevalence | Awareness | Screening | Diagnosis | Treatment | Adherence | Control | Remarks |
---|---|---|---|---|---|---|---|---|---|---|---|
Data as per the MAPS inclusion criteria | |||||||||||
Unstructured | Global Status Report on noncommunicable diseases: 2014 | Global status report tracking worldwide progress in prevention and control of NCDs | Adults (18+ years) | 26.0% | x | x | x | x | x | x | NA |
Supplementary record | Egypt Health Issues Survey: 2015 | Cross-sectional survey | N = 16,671; individuals (15–59 years) interviewed in the survey. | 17.2% (women) 16.7% (men) | x | x | 42.0% | x | x | x | |
Unstructured | Egypt National STEPwise Survey For Noncommunicable Diseases Risk Factors Report; 2017 | National cross-sectional community-based household survey | N = 6680; nationally representative sample of Egyptian adults (15-69 years). | 29.5% | x | x | x | x | x | x | |
Registry of the Egyptian specialized hypertension clinics: patient risk profiles and geographical differences: El Faramawy A; 2019 | Nationwide Specialized Hypertension Clinics Registry | N = 4701; controlled hypertension was defined as BP < 140/90 mmHg in hypertensive patients on antihypertensive medications. | x | x | x | x | x | x | 27.1% | ||
Data deviates from the MAPS inclusion criteria (year limit: 2010–2019) | |||||||||||
Unstructured | Hypertension Prevalence, Awareness, Treatment, and Control in Egypt. Results from the Egyptian National Hypertension Project (NHP): Ibrahim MM; 1995 | Cross-sectional nationwide survey | N = 6733; survey participants (25 to 95 years). | 26.3% | 37.5% | x | x | 24.0% | x | 8.0% | NA |
Patterns and determinants of treatment compliance among hypertensive patients: Youssef RM; 2002 | Multistage random sampling technique | N = 316; hypertensive patients attending health insurance clinics for prescription refills were randomly selected and interviewed. | x | x | x | x | x | 51.9% | 53.2% | ||
Supplementary record | Prevalence and determinants of hypertension unawareness in Egyptian adults: a cross-sectional study of data from the 2015 Egyptian Health Issues Study: Soliman SS; 2020 | Cross-sectional study using data from the 2015 Egyptian Health Issues Survey (EHIS) | N = 2869; participants (≥18 years) were included if they measured blood pressure (systolic and/or diastolic pressure ≥ 140/90 mmHg). | x | 43.9% | x | x | x | x | 22.7% | |
Data deviates from the MAPS inclusion criteria (definitions/special patient subgroups) | |||||||||||
Structured | Lipid profile in Egyptian patients with coronary artery disease: Ibrahim MM; 2013 | Retrospective study of patients with CAD | N = 1000; CAD patients ranged from 19 to 90 years. | 56.7% | x | x | x | x | x | x | Data extracted from patients with stable CAD or had a history of MI |
Control of hypertension with medication: a comparative analysis of national surveys in 20 countries: Ikeda N; 2014 | Systematic search of national health examination surveys from 20 countries | N = 3342; Individuals (35–49 years). | 12.1% | x | x | 64.7% | 54.1% | x | 39.5% | Hypertension definition is based on Systolic blood pressure (i.e., < 140 mmHg) | |
Comparative study between elderly and younger patients with acute coronary syndrome: Obaya M; 2015 | Retrospective registry | N = 570; ACS patients were divided into 2 groups: elderly ≥ 60 years; younger < 60 years. | 49.1 | x | x | x | x | x | x | Data extracted from younger patients (< 60 years) presenting with ACS; hypertension not defined | |
The pattern of risk-factor profile in Egyptian patients with acute coronary syndrome: phase II of the Egyptian cross-sectional CardioRisk project: Reda A; 2019 | Multi-center, observational, cross-sectional study of ACS patients | N = 1681; ACS patients (≥18 years) having a history of hypertension or blood pressure (systolic and/or diastolic pressure ≥140/90 mmHg). | 59.0% | x | x | x | x | x | x | Data extracted on investigating ACS patients |